Medpace Holdings (MEDP) Cash from Financing Activities (2015 - 2026)

Medpace Holdings (MEDP) has reported Cash from Financing Activities for 12 consecutive years, with $12.7 million the latest figure, recorded in Q1 2026.

• Cash from Financing Activities for Q1 2026 came in at $12.7 million, up 103.66% year-over-year; the trailing twelve-month figure through Mar 2026 was -$501.8 million (up 1.16% YoY), and the FY2025 annual result was -$860.4 million, down 458.66% from the prior year.
• Cash from Financing Activities was $12.7 million for Q1 2026 at Medpace Holdings, down from $22.7 million in the prior quarter.
• Over five years, Cash from Financing Activities peaked at $22.7 million in Q4 2025 and troughed at -$540.6 million in Q2 2025.
• Average Cash from Financing Activities over 5 years is -$115.3 million, with a median of -$52.7 million recorded in 2023.
• Year-over-year, Cash from Financing Activities jumped 114.54% in 2024 and tumbled 81265.77% in 2025.
• Over 5 years, Cash from Financing Activities stood at -$131.1 million in 2022, then soared by 101.16% to $1.5 million in 2023, then sank by 11170.85% to -$168.6 million in 2024, then jumped by 113.48% to $22.7 million in 2025, then tumbled by 44.26% to $12.7 million in 2026.
• Per Business Quant data, the three most recent Cash from Financing Activities figures were $12.7 million in Q1 2026, $22.7 million in Q4 2025, and $3.4 million in Q3 2025.